Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 5/20 | 0.38 |
| ▸ | CES2 | O00748 | 4/20 | 0.38 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | F2 | P00734 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | F12 | P00748 | 1/20 | 0.35 |
| ▸ | F7 | P08709 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2103298 | 0.81 | TSHR (0.46) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL1062320 | 0.81 | CES1 (0.39) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL3940728 | 0.80 | TSHR (0.56) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL3940726 | 0.80 | TSHR (0.56) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL15302785 | 0.77 | CES2 (0.41) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL7875628 | 0.75 | TSHR (0.50) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL59763 | 0.75 | TSHR (0.50) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL18294893 | 0.72 | ESR1 (0.50) | TSHRDAONAPRTALDH1A1HIF1A | |
| SCHEMBL724164 | 0.72 | CES1 (0.41) | TSHRDAONAPRTALDH1A1CES1 | |
| SCHEMBL15301913 | 0.72 | ATM (0.43) | ALDH1A1HIF1ACES1CES2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12466850-B2 | Method for producing peptide compound | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-11 | — | — | US | disclosed |
| EP-4023661-B1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-114206901-B | Process for producing peptide compound | 日产化学株式会社 | 2024-02-20 | — | — | CN | disclosed |
| US-20220306682-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | NISSAN CHEMICAL CORPORATION (JP) | 2022-09-29 | — | — | US | disclosed |
| EP-4023661-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | Nissan Chemical Corporation (JP) | 2022-07-06 | — | — | EP | disclosed |
| CN-114206901-A | Method for producing peptide compound | 日产化学株式会社 | 2022-03-18 | — | — | CN | disclosed |
| CN-109415447-B | Silane-mediated enhancement of rubber storage stability | 盛禧奥欧洲有限责任公司 | 2021-06-15 | — | — | CN | disclosed |
| WO-2021039901-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | 日産化学株式会社 | 2021-03-04 | — | — | WO | disclosed |
| US-10858377-B2 | Multivinylaminosilanes as branching agents for functionalized elastomeric polymers | TRINSEO EUROPE GMBH (CH) | 2020-12-08 | — | — | US | disclosed |
| CN-107406467-B | Polyvinylaminosilanes as branching agents for functionalized elastomeric polymers | 盛禧奥欧洲有限责任公司 | 2020-11-10 | — | — | CN | disclosed |
| US-20180030070-A1 | Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers | TRINSEO EUROPE GMBH (CH) | 2018-02-01 | — | — | US | disclosed |
| WO-2017216344-A1 | SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY | TRINSEO EUROPE GMBH (CH) | 2017-12-21 | — | — | WO | disclosed |
| EP-3257869-A1 | SILANE-MEDIATED ENHANCEMENT OF RUBBER STORAGE STABILITY | Trinseo Europe GmbH (CH) | 2017-12-20 | — | — | EP | disclosed |
| WO-2016131590-A1 | MULTIVINYLAMINOSILANES AS BRANCHING AGENTS FOR FUNCTIONALIZED ELASTOMERIC POLYMERS | TRINSEO EUROPE GMBH (CH) | 2016-08-25 | — | — | WO | disclosed |
| EP-3059240-A1 | Multivinylaminosilanes as branching agents for functionalized elastomeric polymers | Trinseo Europe GmbH (CH) | 2016-08-24 | — | — | EP | disclosed |
| US-8871890-B2 | Curable resin composition and cured article | DAICEL CORPORATION (JP) | 2014-10-28 | — | — | US | disclosed |
| EP-2636706-A1 | CURABLE RESIN COMPOSITION AND CURED ARTICLE | Daicel Corporation (JP) | 2013-09-11 | — | — | EP | disclosed |
| US-20130131265-A1 | CURABLE RESIN COMPOSITION AND CURED ARTICLE | DAICEL CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-8404584-B2 | Method of manufacturing semiconductor device | FUJITSU LIMITED (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110207319-A1 | METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE | FUJITSU LIMITED (JP) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030070-A1 | Multivinylaminosilanes as Branching Agents for Functionalized Elastomeric Polymers | GMNN, GNE, MSN | TSHR 2520/4885DAO 1066/4885NAPRT 2635/4885 |
| US-12466850-B2 | Method for producing peptide compound | VIP, NGLY1, NPR1 | TSHR 288/4885DAO 512/4885NAPRT 4130/4885 |
| US-20220306682-A1 | METHOD FOR PRODUCING PEPTIDE COMPOUND | VIP, NGLY1, NPR1 | TSHR 288/4885DAO 512/4885NAPRT 4130/4885 |
| US-10858377-B2 | Multivinylaminosilanes as branching agents for functionalized elastomeric polymers | GMNN, GNE, MSN | TSHR 2520/4885DAO 1066/4885NAPRT 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.